International Journal of Food Science
Volume 2020 (2020), Article ID 3436940, 11 pages
https://doi.org/10.1155/2020/3436940

Research Article

Antioxidant Activity, Enzyme Inhibition Potentials, and Phytochemical Profiling of Premna serratifolia L. Leaf Extracts

Adelina Simamora,1,2 Adit W. Santoso,² Kris H. Timotius,1,2 and Ika Rahayu1,2

¹Department of Biochemistry, Faculty of Medicine and Health Sciences, Krida Wacana Christian University, West Jakarta 11510, Indonesia
²Centre for Enzyme in Health and Diseases, Krida Wacana Christian University, West Jakarta 11510, Indonesia

Correspondence should be addressed to Kris H. Timotius; kh_timotius@ukrida.ac.id

Received 21 March 2020; Revised 24 August 2020; Accepted 31 August 2020; Published 24 September 2020

Academic Editor: Alejandro Castillo

Copyright © 2020 Adelina Simamora et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Premna serratifolia, commonly known as Arogo in Tentena-Sulawesi, is a popular vegetable. As a promising herbal tea and food ingredient, further investigation is required to find the best knowledge for medicinal use of P. serratifolia leaves. This research investigated the antioxidant activity of the ethanol (EEPS) and water (WEPS) extracts of P. serratifolia leaves, based on their scavenging activities on DPPH radicals and their reducing capacities (CuPRAC, total antioxidant/phosphomolybdenum, and ferric thiocyanate reducing power assays). The DNA-protecting effect by EEPS was tested using pBR322 plasmid DNA against •OH radical-induced damage. The inhibition potentials of both extracts against several enzymes related to metabolic diseases (α-glucosidase, α-amylase, xanthine oxidase, and protease) were evaluated. The phytochemical analysis was conducted by an LC-QTOF-MS/MS technique. EEPS proved to be a better antioxidant and had higher phenolic content compared to WEPS. EEPS demonstrated a protective effect on DNA with recovery percentage linearly correlated with EEPS concentrations. Strong inhibition on α-glucosidase and α-amylase was observed for EEPS; however, EEPS and WEPS showed weak inhibitions on xanthine oxidase and protease. LC-QTOF-MS/MS analysis identified seven main components in EEPS, namely scroside E, forsythoside A and forsythoside B, lavandulifolioside, diosmin, nobilin D, campneoside I, and isoacteoside. These components may be responsible for the observed enzymes inhibitions and antioxidant properties. Premna serratifolia leaves can be an appropriate choice for the development of nutraceutical and drug preparations.

1. Introduction

Metabolic diseases including type 2 diabetes mellitus (T2DM) and hyperuricemia have become major public health problems with increasing prevalence worldwide [1]. These diseases have been known to be related to the development of cardiovascular diseases. In each case, abnormally high enzyme activity is observed, such as α-glucosidase and xanthine oxidase activities for diabetes mellitus and gouty arthritis, respectively. Enzyme inhibition and the treatment for inflammation, as in the case in gouty arthritis, have become effective clinical approaches for the treatment of these diseases [2]. Synthetic inhibitors are the first-line drugs prescribed for the management of these disorders, such as acarbose for type 2 diabetes mellitus (T2DM), allopurinol for gouty arthritis, and sodium diclofenac for the treatment of inflammation. However, they reportedly cause unfavorable side effects. Acarbose has been associated with abdominal discomfort and hepatotoxicity [3]. Allopurinol also presents some adverse effects such as allergy, liver function abnormalities, and nephropathy [4]. Nonsteroidal anti-inflammatory drugs cause gastrointestinal and renal toxicities [5]. Therefore, it is of great priority to find new enzyme inhibitors that are more affordable and less toxic and have fewer side effects.

Plants have been a potential source for the discoveries of pharmacological active compounds including enzyme inhibitors that can be used as lead compounds for drug development. Plants can also be used as dietary adjunct to the existing therapy. Studies have evidenced that plant-based bioactive compounds demonstrated efficient inhibition to relevant enzymes associated with metabolic diseases [6, 7].

The species Premna serratifolia belongs to the family Lamiaceae. It is native to tropical and subtropical regions, including Indonesia, Australia, and India. The shrub plants can grow up to one and half meters. The leaves of P. serratifolia are commonly consumed as food ingredient in Tentena, Central Sulawesi, Indonesia, where it is known as Arogo. Different parts of P. serratifolia including fruit, roots, barks, and leaves have been used in folk medicine for the treatment of a number of illnesses, such as stomach disorders, diabetes, cough, rheumatism, inflammatory, and cardiovascular disorder [8]. Pharmacological studies conducted so far confirm on the ethnomedicinal uses of P. serratifolia including antioxidant, antiarthritis, antiparasitic, and cardio- and gastroprotective activities [9]. To date, studies conducted on P. serratifolia mainly involve roots, barks, woods, and stems from the plant. Only few papers have been published regarding the pharmacological properties of the leaves of P. serratifolia, such as tumor cell suppression activity [10], cytotoxic activities on neuroblastoma and melanoma cell lines [11], and anti-inflammatory and anticancer activities using animal model [12, 13]. Recently, we reported antidiabetic and antioxidant properties of the water extract of P. serratifolia leaves [14]. The present study aimed at extending this investigation on the antioxidant (reducing power and DNA protective) activities and enzyme (α-glucosidase, α-amylase, xanthine oxidase, and protease) inhibitory properties, of the water and ethanol extracts. Furthermore, the phytochemical profiles of the ethanol extract were also reported.

2. Materials and Methods

2.1. Chemicals

Acarbose, AlCl₃ 6.H₂O, allopurinol, porcine pancreatic α-amylase (EC 3.2.1.1), 2,2-diphenyl-1-picrylhydrazyl (DPPH), Folin-Ciocalteu reagent, p-nitrophenyl α-D-glucopyranoside (p-NPG), Na-diclofenac, orlistat, rutin, protease (EC 3.4.23.6), xanthine, and xanthine oxidase from bovine milk (EC 1.17.3.2) were obtained from Sigma-Aldrich (St. Louis, USA). PBR322 plasmid DNA was obtained from BioLabs (Boston, USA). Ammonium molybdate, NaNO₂, and starch were purchased from Merck (Darmstadt, Germany). Gallic acid was purchased from Santa Cruz Biotechnology (Dallas, USA). All remaining reagents were of the highest purity available (>98%). All solvents were of analytical grade.

2.2. Plant Material and Extracts Preparation

The leaves of P. serratifolia were collected from Tentena, Poso, Central Sulawesi, Indonesia, in September 2018. A voucher specimen (KWL017) was deposited. The ethanol extract of P. serratifolia (EEPS) was prepared by macerating 50 g of powdered dried leaves in 500 mL ethanol at room temperature for 3 days in the dark. Following filtration, the solvent was dried under reduced pressure by a rotary evaporator (BUCHI Labortechnik AG, Switzerland). The obtained extract was kept at 4°C in darkness for further analysis. The water extract of P. serratifolia (WEPS) was prepared using 2 g of powdered dried leaves which was decocted in 200 mL of boiled deionized water. The mixture was continuously stirred, and the temperature was kept at 90°C to a final volume of 100 mL. After filtration, the clear filtrate was freeze-dried and kept at 4°C until used. The residue was used to prepare stock sample solution in ethanol for various analysis.

2.3. Total Phenolic Content (TPC)

The phenolic contents of EEPS and WEPS were determined using the Folin-Ciocalteu method as described previously [15]. Sample solution (0.5 mL) was added with 2.5 mL Folin-Ciocalteu reagent (10% , aqueous solution) and left to stand for 10 mins. Sodium carbonate (Na₂CO₃) solution (75 g/L, 2.5 mL) was then added to neutralize the reaction mixture. After incubating for 2 h, the absorbance was read at 765 nm (Biochrom Libra S22, Cambridge, UK). Gallic acid (12.50–200 μg/mL) was used to generate a standard curve.

Results were expressed as mg gallic acid equivalent (mgGAE)/g dried material.

2.4. Total Flavonoid Content (TFC)

The total flavonoid contents were determined based on an aluminium chloride colorimetric method as described previously [16]. The reaction mixture consisted of extract solution (0.5 mL), NaNO₂ (5% , 0.15 mL), AlCl₃ (10% , 0.15 mL), and NaOH (1 M, 2 mL). After incubating for 15 mins, the absorbance was taken at 510 nm. Rutin (6.40–1000 μg/mL) was used to generate a standard curve. Results were expressed as mg rutin equivalent (mgRE)/gram dried material.

2.5. Antioxidant Activity Assays

2.5.1. DPPH Radical Scavenging Assay

The effect of EEPS and WEPS on DPPH radicals was determined based on a method described previously [17]. Different concentrations of leaf extracts (3 mL) were prepared, and into each of these solutions was added DPPH solution in ethanol (1 mL). The mixture was vigorously vortexed, thereafter incubated at room temperature in the dark for 30 mins. The absorbance was read at 517 nm using a spectrophotometer. BHT and ascorbic acid were used as references, and ethanol was used as a negative control. The percentage of scavenging activity was calculated by the following formula:

where A control and A sample are absorbances of negative control and sample, respectively. was calculated from the linear regression equation obtained from the plot of inhibition % against concentration.

2.5.2. Cupric Ion Reducing Antioxidant Capacity (CuPRAC) Assay

The cupric ion reducing antioxidant capacity was determined according to a method described previously [18], with some modifications. Extract solution (0.5 mL) was added into a reaction mixture containing CuCl₂ (10 mM, 1 mL), neocuproine in ethanol (7.5 mM, 1 mL), and NH₄OAc buffer (1 M, 1 mL, pH 7.00). Water was added to make a final volume of 4.1 mL. After incubating for 30 mins, the absorbance was read at 450 nm. The absorbance was read against blank solution which contained all the solution except for the extract. Trolox (10–320 μg/mL) was used to generate a standard curve. Extract activities were expressed as mg trolox equivalent (mgTE)/gram dried material.

2.5.3. Total Antioxidant Assay

The total antioxidant activity of the extracts was determined by a phosphomolybdenum method described previously [19]. Phosphomolybdenum reagent consisted of ammonium molybdate (4 mM), sulfuric acid (0.6 M), and trisodium phosphate (28 mM). In a capped tube, 3 mL of this reagent was added with a sample solution (0.3 mL). The reaction mixture was incubated in water bath at 95°C for 90 mins. After cooling the samples at room temperature, the absorbance was read at 695 nm. The absorbance of blank solution was read by replacing the sample with water. Trolox (40–1000 μg/mL) was used to generate a standard curve. The total antioxidant activity was expressed as mg trolox equivalent (mgTE)/gram dried material.

2.5.4. Reducing Power Assay

The total antioxidant activity of the extracts was determined by the ferric thiocyanate method as described previously [20]. Sample solution in water (1 mL) was mixed with phosphate buffer pH 6.6 (0.2 M, 2.5 mL) and potassium ferric cyanide K₃Fe(CN)₆ (1% , 2.5 mL). The mixture was incubated for 20 mins at 50°C. After cooling at room temperature, tricholoracetic acid (10% , 2.5 mL) was added, and the mixture was centrifuged at 3000 rpm for 10 mins. The upper layer (2.5 mL) was taken out and mixed with water (2.5 mL) and FeCl₃ (1% , 0.5 mL). The absorbance was read at 700 nm. Ascorbic acid (1.56–100 μg/mL) was used to generate a standard curve. Results was presented as mg ascorbic acid equivalent (AAE)/gram dried material.

2.5.5. DNA Protection Assay

Protection against DNA damage by extracts was evaluated using agarose gel electrophoresis as described previously [21] with some modifications. This method was based on the ability of EEPS to protect the supercoiled pBR322 plasmid DNA from •OH radicals induced by Fenton reaction. The reaction system contained 1 μL of plasmid DNA (0.5 μg), 2 μL of FeSO4 (1 mM), 2 μL of H₂O₂ (1 mM), followed by the addition of 5 μL of extract of different concentrations. The final volume was brought to 15 μL by the addition of 5 μL of phosphate buffer saline (PBS, 10 mM, pH 7.4). The reaction mixture was let to incubate at 37°C for 30 min. Thereafter, the reaction was terminated by the addition of 2 μL of a loading buffer consisted of glycerol (50%, ), EDTA (40 mM), and bromophenol blue (0.05%). The mixture was then loaded on 1% agarose gel containing 0.5 μg/mL ethidium bromide in Tris/acetate/EDTA gel buffer and electrophoresis was run for 90 min (80 V) on an electrophoresis instrument (the Gel Doc Azure). The plasmid DNA was visualised and photographed under ultraviolet light. Densitometric analysis was carried out for the quantification of recovery percentage using the ImageJ software (version 52, java 8).

2.6. In Vitro Enzyme Inhibition Assays

2.6.1. α-Glucosidase Inhibition Assay

Inhibition activities on α-glucosidase by the extracts and acarbose (a positive control) were determined according to a reported method [17], using α-glucosidase from Saccharomyces cerevisiae (EC 3.2.2.20) and p-nitrophenyl-α-D-glucopyranoside (pNPG) as a substrate. In brief, 50 μL of sample solution of different concentrations was mixed with phosphate buffer pH 6.8 (50 mM, 50 μL). A solution of α-glucosidase solution (0.5 U/mL, 50 μL) was added, and the reaction mixture was preincubated at 37°C for 5 mins. To start the reaction, pNPG (1 mM, 100 μL) was added, and the reaction mixture was further incubated at 37°C for 20 mins. The reaction was terminated by the addition of Na₂CO₃ (100 mM, 750 μL), and the absorbance was read at 405 nm. Acarbose was used as a positive control. The percentage of inhibitions were calculated by the following formula:

where A control and A sample are absorbances of negative control and sample, respectively. was calculated from the linear regression equation obtained from the plot of inhibition % against concentration.

2.6.2. α-Amylase Inhibition Assay

The inhibition activity of the extracts on α-amylase was determined according to the method described previously [22], with some modifications. Extract of different concentrations (100 μL) was mixed 100 μL of phosphate buffer pH 6.9 (200 mM, with 6 mM NaCl) and pancreatic porcine α-amylase (0.5 mg/mL, 100 μL). The reaction mixture was preincubated at 37°C for 5 mins. To start the reaction, 200 μL of starch solution (1%, in phosphate buffer) was added, and the reaction mixture was further incubated for 10 mins. The reaction was terminated by the addition of 500 μL of dinitrosalicylic acid color reagent. The test tubes were then incubated in a boiling water bath for 5 mins and diluted with water (14 mL). The absorbance was read at 540 nm. The absorbance of blank solution was read by replacing the enzyme with phosphate buffer. The percentage of inhibitions was calculated using the following equation:

where A control and A sample are absorbances of negative control and sample, respectively. was calculated from the linear regression equation obtained from the plot of inhibition % against concentration.

2.6.3. Xanthine Oxidase (XO) Inhibition Assay

Inhibition activity of the extracts on xanthine oxidase (XO) was determined based on the method reported previously [23] with modifications, using porcine pancreatic xanthine oxidase and xanthine as a substrate. Sample of different concentrations (100 μL) was mixed with xanthine oxidase (0.2 U/mL, 100 μL). The reaction mixture was added with phosphate buffer pH 7.4 (50 mM, with 400 μL) and preincubated at 37°C for 5 mins. The reaction was started by the addition of xanthine (0.3 mM, 200 μL) and further incubated at 37°C for 30 mins. Thereafter, HCl (100 mM, 200 μL) was added to stop the reaction, and the absorbance was measured at 290 nm. The absorbance was read against blank solution in which the enzyme was replaced by phosphate buffer. Allopurinol was used as a positive control, and buffer was used as a negative control. The percentage of inhibitions was calculated by the following formula:

where A control and A sample are absorbances of negative control and sample, respectively. was calculated from the linear regression equation obtained from the plot of inhibition % against concentration.

2.6.4. Protease Inhibition Assay

Inhibition activity of the extracts on protease was determined using a modified method described previously [24], using azocasein as a substrate and protease. The reaction mixture consisted of azocasein (5 mg/mL, 100 μL), protease (0.08 U/mL, 50 μL), and extracts of various concentrations (50 μL), and the mixture was incubated for 90 mins at 37°C. Thereafter, TCA (5% , 400 μL) was added, and the mixture was centrifuged at 15,000 rpm for 10 mins. The supernatant was added with NaOH (0.56 M, 700 μL). The absorbance was read at 442 nm. Sodium diclofenac was used as a positive control, and buffer solution was used as a negative control. The percentage of inhibitions was calculated by the following formula:

where A control and A sample are absorbances of negative control and sample, respectively. was calculated from the linear regression equation obtained from the plot of inhibition % against concentration.

2.7. LC-QTOF-MS/MS Analysis

EEPS was subjected to an LC-QTOF-MS/MS analysis using an Acquity UPLC system (Waters Corp., Milford, MA, USA), coupled with an MS/MS detector of XEVO G2-S QTOF model. The chromatographic separation was carried out using a C18 column. The eluent gradient was consisted of mobile phase A (0.1% formic acid in acetonitrile) and mobile phase B (0.1% formic acid in water). The solvent flow rate was maintained at 0.6 mL/min at 40°C. A QTOF mass spectrophotometer equipped with an electrospray ionization (ESI) source was used to perform the MS analysis, using positive and negative modes. The MS conditions were as follows. The acquisition range was 50 to 1200 Da, and the source temperature was 120°C. The capillary voltage was at 2.0 kV, and cone voltage at 40 V. The collision energy varied between 15 and 40 V. The desolvation gas flow was maintained at 1000 L/h, and the desolvation temperature at 550°C.

2.8. Statistical Analysis

All experiments were conducted in three repeats. Results were presented as (SD). Students’ -test and one-way ANOVA (SPSS software version 23 for Windows) were used to analyse the difference, and was considered to be statistically significant.

3. Results and Discussion

3.1. Total Phenolic (TPC) and Total Flavonoid Contents (TFC)

The total phenolic and flavonoid contents of EEPS and WEPS are presented in Table 1. A significant difference in TPC () was observed between EEPS and WEPS, with EEPS showing a more concentrated phenolics, approximately 7–8 folds, than WEPS. However, WEPS was observed to have higher content in flavonoids compared to EEPS (). Plant-based phenolics and flavonoids have been associated with medicinal properties. Extraction of these metabolites from plant preparations is known to be influenced by solvent polarity, as also observed in the present study. Results indicate that ethanol, a less polar solvent than water, was a more effective extractant for phenolic compounds recovery from the P. serratifolia leaves. Some earlier reports indicated similar pattern, in which ethanol extracts contained higher phenolics and lower flavonoids when compared with water extracts [25]. This could be due to the solubility difference of various heterogeneous structures of phenolic and flavonoid compounds in each extract. More specifically, several phenylethanoid glycosides (PhGs), which were identified by the LC-QTOF-MS/MS analysis (part 3.4, Table 3), were abundant in polyphenolic structures, such as isoacteoside, forsythoside A and B, lavandulifolioside, scroside E, and campneoside I. PhGs were known to be soluble in polar solvents (water) due to their glycoside substituents. Furthermore, the LC-QTOF-MS/MS also identified diosmin, a flavon glycoside. It is also worth pointing that a significant amount of phenolics and flavonoids present in the water extract suggests its application in domestic context.

Table 1: Total phenolic and flavonoid contents of P. serratifolia leaf extracts.

Total phenolic content (mgGAE/g dried biomass)
Total flavonoid content (mgRE†/g dried biomass)

Ethanol

Water

mgGAE (mg gallic acid equivalent). †mgRE (mg rutin equivalent). ‡Values expressed as ().

3.2. Antioxidant Activities

Antioxidant activity of the extracts was evaluated using different methods which differ in terms of mechanisms and reaction conditions. EEPS and WEPS were determined for their radical scavenging activity based on DPPH assay and their reducing capacity (CUPRAC, phosphomolybdenum, and reducing power assays). DNA damage protection capacity was also evaluated as part of antioxidant activities of EEPS. Results are presented in Table 2.

Table 2: Antioxidant activities of P. serratifolia leaf extracts.

DPPH scavenging (μg/mL)
CUPRAC mgTE/g dried biomass
Phosphomolybdenum mgTE/g dried biomass
Reducing power mgAAE†/g dried biomass

Ethanol

Water

Ascorbic acid

NA
NA
NA

mgTE: mg/trolox equivalent. †mgAAE: mg/ascorbic acid equivalent.

EEPS and WEPS exhibited potent scavenging activities on DPPH radicals, with comparable to that of the standard ascorbic acid. Stronger activity was observed for EEPS than WEPS (). Scavenging activities found in these extracts are in agreement with previous studies [14, 26]. Previously, extract of other part of P. serratifolia has been reported to have good activity on DPPH radicals. Ethanol wood extract showed to have of 155 μg/mL [27], which was weaker than ethanol leaf extract observed in the present study.

CUPRAC, phosphomolybdenum and reducing power assays were employed to evaluate the reducing potential of the extracts. The methods are based on the reduction of Cu(II) to Cu(I) in acidic condition, Mo(VI) to Mo(V), and Fe(III) to Fe(II), respectively. Higher values indicate higher reducing capacity. By all methods, both EEPS and WEPS showed reducing ability as can be seen in Table 2. However, EEPS consistently exhibited higher reducing activities compared to WEPS (), suggesting a stronger antioxidant activity. Antioxidant activities of various Premna species have been reported previously. Premna corymbosa and Premna mucronata previously showed to have reducing power capacity [28].

Previous studies have demonstrated that antioxidant activity of the plant extracts was strongly related to their phenolic content [15, 29]. This present work proved the antioxidant activity of P. serratifolia leaves, which derives from radical scavenging and reducing activities. It is worth noting that EEPS showed higher content in phenolics compared to WEPS. The difference in activity registered to EEPS and WEPS may be associated to the content of the phenolics in the extracts as observed previously (part 3.1). Furthermore, PhGs as identified in the ethanol extract by the LC-QTOF-MS/MS were rich in phenolic structures such as isoactoside, forsythoside A and B, lavandulifolioside, scroside E, and campneoside I. Phenolic compounds contain one or more hydroxyl moieties on the benzene ring. The acidic properties of the hydroxyl group and the nucleophilic property of the benzene rings are responsible for the antioxidant activity of the phenolics, possibly by donating a proton or an electron to scavenge free radicals or involving in reducing metal ions of higher oxidation number to lower number.

Oxidative stress is considered central in triggering pathological conditions in hyperglycemia and hyperuricemia. It has been reported that persistent hyperglycemia perpetuated reactive oxygen species (ROS) formation through various pathways, including advanced glycation end-product (AGE), polyol, and protein kinase C pathways [30]. In addition, catalytic oxidation of hypoxanthine to uric acid contributes to the ROS formation. It has been known that pancreatic β-cells are vulnerable to ROS-induced destruction [31]. Further, ROS has been associated with the progression of diabetic complications [32]. Therefore, enhancing cellular antioxidant ability through dietary or supplement intake is key for an effective treatment for T2DM and hyperuricemia.

DNA protection effect was performed to evaluate the ability of EEPS to protect DNA from free radical-induced damage. The approach used in the present study was based on plasmid DNA breakage due to exposure to •OH radicals induced by Fenton reagent. Figure 1 shows the electrophoretic pattern of DNA derived from pBR322 plasmid in the absence and presence of EEPS. Band on lane 7 shows pBR322 plasmid DNA in the absence of Fenton reagent, which was mostly in the supercoiled form with high electrophoretic mobility, as similarly observed in other studies [33]. Exposure of plasmid DNA to •OH radicals was shown to cause DNA strand breakage as indicated by open circular form with low mobility in electrophoreses (band on lane 1). Bands on lanes 2 to 6 were plasmid DNA treated with EEPS in increasing concentrations (0.11–27.33 mg/mL). Upon increasing addition of EEPS, DNA regained its native forms, as indicated by an increase in supercoiled form, thus suggesting the protective effect of the EEPS. Densitometric analysis further confirmed the recovery of the plasmid DNA due to EEPS addition. Positive linear correlation was observed between EEPS additions and DNA percentage of recovery (), suggesting the significant role of the presence of EEPS in protecting DNA. The protective effect may be tentatively be ascribed to the polyphenolics in the extract, as has been shown also by previous studies [34]. Polyphenolics are known to be able to chelate metal ions such as Fe(II) and Cu(II) ions which participate in the formation of •OH radicals [35]. In particular, several phenylethanoid glycosides (PhGs) identified in this study contain polyphenolic structures that may be able to chelate these metal ions, such as isoactoside, forsythoside A and B, scroside E, and campneoside I. In fact, lavandulifolioside, which was identified in our extract, has been evidenced to exert protection effect on DNA in vitro [36].

(a)

(b)

Figure 1: DNA protective effect of EEPS. (a) Lane 1: DNA + H₂O₂/Fe²⁺, lanes 2–6: DNA + H₂O₂/Fe²⁺ treated with EEPS (0.11, 0.43, 1.71, 6.83, and 27.33 mg/mL), lane 7: native DNA. (b) Concentration-dependent response of protective effect against DNA damage.

3.3. Enzyme Inhibitory Activities

The antidiabetic potential of EEPS and WEPS were investigated based on their inhibition activities against α-glucosidase and α-amylase. Both enzymes are key in the digestion of polysaccharides, subsequently modulating postprandial blood glucose.

Both extracts were actively inhibited α-glucosidase, with inhibition percentages linearly correlated with concentrations (Figure 2(a)). However, significant difference in inhibition activity was observed between EEPS and WEPS (). The of EEPS and WEPS was and , indicating that EEPS had a stronger inhibition effect on α-glucosidase than WEPS. In the present study, acarbose was used as a reference, yielding of . These results suggest that acarbose had more potent inhibition activity than EEPS and WEPS. Acarbose, a prescribed antidiabetic agent, is known to act through inhibition on α-glucosidase in a competitive mode, similar to that of WEPS, as previously reported [17].

(a)

(b)

(c)

(d)

Figure 2: Concentration-response curves for the inhibition of EEPS, WEPS, and controls on (a) α-glucosidase, (b) α-amylase (c), xanthine oxidase, and (d) protease.

EEPS was observed to have a potent inhibitory activity on α-amylase compared to WEPS. As shown in Figure 2(b), the inhibitory activity increased with increasing EEPS concentrations, although a lower activity was obtained than acarbose ( values of and , respectively). However, it was observed that WEPS had no inhibitory activity on α-amylase.

This study demonstrated that P. serratifolia leaves are inhibitors of α-glucosidase and α-amylase. This observation is in agreement with our previous study, in which it was shown that water extract inhibited α-glucosidase in a competitive mode [14]. On a previous report, the leaves of P. serratifolia have been reported to have hypoglycemic activity using animal model [37]. The present study indicates that the antidiabetic effect is probably mediated by its inhibition effect on α-glucosidase and α-amylase. Previous study on P. serratifolia using water extract has demonstrated close association between α-glucosidase inhibitory effect and total phenolic contents in the water extract [15]. PhGs, such as isoacteoside which was identified in our extract by mass spectrophotometry analysis, were previously reported to have hypoglycemic activity through its action on α-glucosidase [38]. In addition, isoacteoside was also shown to be able to inhibit the formation of AGE, which is a substance that can induce insulin resistance in adipocytes, hepatocytes, and muscle cells in mouse [39].

WEPS and EEPS showed a concentration-dependent activity on XO inhibition (Figure 2(c)). EEPS showed an appreciable inhibition activity on XO (), significantly stronger than WEPS () which showed a modest activity on XO (). However, the observed activity on EEPS is considerably weaker than allopurinol, a reference XO inhibitor, which displayed of .

Xanthine oxidase (XO) plays an important role in catalyzing the hydroxylation reaction of hypoxanthine to xanthine and ultimately to uric acid. An elevated level of blood uric acid (hyperuricemia) is pathological since it leads to the formation and deposition of monosodium urate crystal in the joints that causes gouty arthritis. In addition, the catalytic reaction also generates superoxide radicals, which contributes to oxidative stress condition. Lowering serum urate is an important approach in the management of hyperuricemia. Thus, inhibition on XO has become a therapeutic target in the treatment of hyperuricemia. The present study revealed that P. serratifolia leaf extracts demonstrated appreciable inhibition activities on XO. Previously, ethanolic wood extract of P. serratifolia was proven to have antiarthritis activity using animal model [40, 41]. However, to the extent of our knowledge, this is the first time XO activity of P. serratifolia leaves was reported. Finding in this study suggests that the leaf extracts of P. serratifolia are able to decelerate uric acid formation through inhibition on XO, thus can be beneficial in mitigating hyperuricemia and ROS generation. XO activity observed in EEPS and WEPS may be attributed to the phenolic compounds in the extracts, as have been shown by previous studies [42]. Several PhG compounds have been shown to have hypouricemia activity using hyperuricemic mice induced by potassium oxonate [43].

Proteases are involved in almost all biological processes in organisms, including metabolic and physiological processes, indicating their crucial role in maintaining homeostasis. Indeed, unregulated and excessive protease activity has been implicated in pathological conditions, such as in neurodegenerative, cancer, and autoimmune and inflammatory diseases [44]. Therefore, inhibition on proteases is a potential target on the development of therapeutic drugs. In the present study, EEPS and WEPS were screened for their inhibition activity on protease. As shown in Figure 2(d), EEPS showed inhibition activity against protease in a concentration-dependent manner (the of EEPS ). However, the activity was observed to be much weaker compared to the positive control sodium diclofenac (), which was a nonsteroidal anti-inflammatory drug. Results in the present study indicate that P. serratifolia leaves are able to modulate protease activities thus can be further explored as a potential source for plant-based proteases inhibitors. To date, limited studies have been reported for plant-based protease inhibitors.

3.4. LC-QTOF-MS/MS Analysis of the Ethanol Extract

Similar to the other members that belong to the family Lamiaceae, P. serratifolia is characterized by its phenylethanoid glycosides (PhGs). In fact, the main components identified in EEPS by LS-QTOF-MS/MS (Table 3) are of PhGs derivatives, i.e., isoactoside, forsythoside A and B, lavandulifolioside, scroside E, and campneoside I. Nobilin D is one of the major compounds in EEPS which is not of PhGs. Chromatogram of the LC-QTOF-MS/MS is shown in Figure 3. The PhGs have been studied for their multiple therapeutic potentials. It could be that PhGs identified in the leaf extract of P. serratifolia justify its therapeutic use in folk medicine.

Table 3: Major compounds identified in the ethanol extract of P. serratifolia leaves using LC-QTOF-MS/MS based on positive and negative modes.

Compounds
RT
Area (%)
Formula
ESI
[M-H]⁺/⁻[M-H]⁻ ()
Major fragment

Scroside E
7.22
12.36
C₃₀H₃₈O₁₆
+
673
672, 293, 147

7.48
11.34
—
671
653

Campneoside I
8.17
4.45
C₃₀H₃₈O₁₆
—
653
653

Forsythoside B
8.32
15.51
C₃₄H₄₄O₁₉
—
756
755

Forsythoside A
8.49
31.33
C₂₉H₃₆O₁₅
+
625
663, 642, 608, 325, 163

Isoacteoside
8.50
44.17
C₂₉H₃₆O₁₅
—
623
623

Lavandulifolioside
8.60
22.75
C₃₄H₄₄O₁₉
—
755
755

8.60
30.57
+
757
774, 325

Diosmin
9.42
9.23
C₂₈H₃₂O₁₅
+
609
609, 325, 463

Nobilin D
12.24
8.75
C₁₇H₂₀O₆
+
321
307, 161

(a)

(b)

Figure 3: LC-QTOF-MS/MS chromatogram of major compounds identified in ethanol extract of P. serratifolia leaves using (a) negative and (b) positive modes.

Isoacteoside was the most dominant compound found in EEPS. Isoacteoside is a dihydroxypheynylethyl glycoside, which was also reported to exhibit multiple biological activities. Isoacteoside isolated from Abeliophyllum distichum was evidenced to have anti-inflammatory activity, by suppressing the production and expression of proinflammatory cytokines [45]. In addition, isoacteoside had the capacity to decrease amyloid-β deposition and cytotoxicity by preventing amyloid-β aggregation, suggesting its therapeutic potential for Alzheimer’s diseases [46].

Forsythoside A (FTA) has been recognized to be responsible for multiple biological activities. Zeng et al. reported that FTA showed antiendotoxin or lipopolysaccharides (LPS) activity, exerting its anti-LPS effect by inhibiting the TLR4 signaling pathway [47]. LPS is one of bacterial products, and a high level of LPS in blood is associated with multiple organ dysfunctions and failures. Recently, FTA and campneoside I isolated from cell lines of Syringa vulgaris L. were evidenced to have good antioxidant activity, by inducing NRF2 protein which is a regulator of heme oxygenase 1 (HMOX1) [48]. Extract containing campneoside I showed antibacterial activity against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus faecium. From such antibacterial activity, the methoxy group of campneoside I was postulated to be the essential element for the antibacterial activity [49].

Forsythoside B (FTB) isolated from Ballota nigra showed antimicrobial activity against Proteus mirabilis and Staphylococcus aureus including one methicillin-resistant strain [50].

Lavandulifolioside was known to have cardiotonic pharmacological effects. In some in vivo studies, lavandulifolioside isolated from Leonurus cardiaca was evidenced to have antiarrhythmic effect [51]. Lavandulifolioside and Isoacteoside isolated from Plantago lanceolata L. reportedly had antispasmodic activity by inhibiting contractions induced by acetylcholine in animal model [52].

Diosmin is a flavone derivative which is also known as venosmine. In recent studies, anticancer activity was reported for diosmin against lung and breast cancer cell lines. The activity was enhanced by using diosmin-oxidovanadium (IV) complex compound [53]. Administration of diosmin to diabetic rats induced by streptozotocin proved to decrease the oxidative stress, as seen from the increase in antioxidant status of glutathione peroxidase, superoxide dismutase, and catalase levels [54].

It has been shown that nobilin D isolated from Dendrobium nobile exhibited better radical scavenging activities on DPPH and NO radicals, compared to vitamin C and resveratrol, in respective assays [55].

4. Conclusion

Taking all the above findings into consideration, we can come to the conclusion that EEPS and WEPS exhibited appreciable range of activities on antioxidant and inhibition on α-amylase and α-glucosidase. Both were not strong inhibitor for xanthine oxidase and protease. Therefore, EEPS and WEPS can be explored as a potential source of bioactive compounds for preventing metabolic syndromes. Phenylethanoid and flavone glycoside derivatives, which have various beneficial functions in health care, are the most detected compounds in ethanol extract from P. serratifolia leaves.

Data Availability

All data used in the manuscript are already included in the manuscript.

Conflicts of Interest

The authors declare no potential conflict of interest.

Acknowledgments

The authors are grateful for the financial support from the Research Institute of Krida Wacana Christian University (Grant number: 13/UKKW/LPPM-FK/Lit/VIII/2018). The authors are thankful for the use of laboratory facilities of the Faculty of Medicine Krida Wacana Christian University. The authors also thank PT Saraswanti Indo Genetech for technical help with LC-QTOF-MS/MS.

References

J. X. Moore, N. Chaudhary, and T. Akinyemiju, “Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988–2012,” Preventing Chronic Disease, vol. 14, 2017.

F. Lioté, “Treatment of hyperuricemia, gout and other crystalline arthritidies,” Reumatismo, vol. 63, no. 4, pp. 276–283, 2012.

J. J. Marín-Peñalver, I. Martín-Timón, C. Sevillano-Collantes, and F. J. del Cañizo-Gómez, “Update on the treatment of type 2 diabetes mellitus,” World Journal of Diabetes, vol. 7, no. 17, pp. 354–395, 2016.

N. Dubchak and G. F. Falasca, “New and improved strategies for the treatment of gout,” International Journal of Nephrology and Renovascular Disease, vol. 3, pp. 145–166, 2010.

M. Sinha, L. Gautam, P. K. Shukla, P. Kaur, S. Sharma, and T. P. Singh, “Current perspectives in NSAID-induced gastropathy,” Mediators of Inflammation, vol. 2013, Article ID 258209, 11 pages, 2013.

M. S. Costamagna, I. C. Zampini, M. R. Alberto et al., “Polyphenols rich fraction from Geoffroea decorticans fruits flour affects key enzymes involved in metabolic syndrome, oxidative stress and inflammatory process,” Food Chemistry, vol. 190, pp. 392–402, 2016.

A. Mun'im, A. Andriani, K. F. Mahmudah, and M. Mashita, “Screening of α-glucosidase inhibitory activity of some Indonesian medicinal plants,” International Journal of Medicinal and Aromatic Plants, vol. 3, no. 2, pp. 144–150, 2013.

U. Quattrocchi, CRC World Dictionary of Medicinal and Poisonous Plants: Common Names, Scientific Names, Eponyms, Synonyms, and Etymology (5 Volume Set), CRC press, Boca Raton, FL, USA, 2012.

R. Dianita and I. Jantan, “Ethnomedicinal uses, phytochemistry and pharmacological aspects of the genusPremna: a review,” Pharmaceutical biology, vol. 55, no. 1, pp. 1715–1739, 2017.

T. N. Selvam, S. D. Kumar, V. Venkatakrishnan, and P. Elumalai, “Antioxidant and tumor cell suppression potential of Premna serratifolia Linn leaf,” Toxicology International, vol. 19, no. 1, pp. 31–34, 2012.

S. Habtemariam and G. K. Varghese, “A novel diterpene skeleton: identification of a highly aromatic, cytotoxic and antioxidant 5-methyl-10-demethyl-abietane-type diterpene fromPremna serratifolia,” Phytotherapy Research, vol. 29, no. 1, pp. 80–85, 2015.

H. Kumari, P. Shrikanth, R. P. Chaithra, and K. Nishteswar, “A comparative experimental evaluation of anti-inflammatory activity of Premna obtusifolia Linn and Premna latifolia Roxb leaves in Charles foster rats,” Ancient science of life, vol. 31, no. 2, pp. 58–61, 2011.

P. Y. Mali, “Pharmacological potentials of Premna integrifolia L,” Ancient science of life, vol. 35, no. 3, pp. 132–142, 2016.

K. H. Timotius, A. Simamora, and A. W. Santoso, “Chemical characteristics and in vitro antidiabetic and antioxidant activities of Premna serratifolia L. leaf infusion and decoction,” Pharmacognosy Journal, vol. 10, no. 6, pp. 1114–1118, 2018.

V. Singleton and J. A. Rossi, “Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents,” American Journal of Enology and Viticulture, vol. 65, no. 3, pp. 144–158, 1965.

A. Simamora, L. Paramita, N. Azreen, A. W. Santoso, and K. H. Timotius, “In vitro antidiabetic and antioxidant activities of aqueous extract from the Leaf and fruit of Psidium guajava L,” Indonesian Biomedical Journal, vol. 10, no. 2, pp. 156–164, 2018.

A. Simamora, A. W. Santoso, and K. H. Timotius, “α-Glucosidase inhibitory effect of fermented fruit juice of Morinda citrifolia L and combination effect with acarbose,” Current Research in Nutrition and Food Science, vol. 7, no. 1, pp. 218–226, 2019.

H. H. Orak, I. S. Bahrisefit, and T. Sabudak, “Antioxidant activity of Extracts of soursop (Annona muricata L.) leaves, fruit pulps, peels, and seeds,” Polish Journal of Food and Nutrition Sciences, vol. 69, no. 4, pp. 359–366, 2019.

P. Prieto, M. Pineda, and M. Aguilar, “Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of Vitamin E,” Analitical Biochemistry, vol. 269, no. 2, pp. 337–341, 1999.

A. Costa-Mugica, A. E. Batista-Gonzalez, D. Mondejar et al., “Inhibition of LDL-oxidation and antioxidant properties related to polyphenol content of hydrophilic fractions from seaweed Halimeda Incrassata (Ellis) Lamouroux,” Brazilian Journal of Pharmaceutical Sciences, vol. 48, no. 1, pp. 31–37, 2012.

J. H. Jeong, “Antioxidant and Antimicrobial Activities of Extracts from a Medicinal Plant, Sea Buckthorn,” Journal of the Korean Society for Applied Biological Chemistry, vol. 53, no. 1, pp. 33–38, 2009.

J. Gao, P. Xu, Y. Wang, Y. Wang, and D. Hochstetter, “Combined effects of green tea extracts, green tea polyphenols or epigallocatechin gallate with acarbose on inhibition against α-amylase and α-glucosidase in vitro,” Molecules, vol. 18, no. 9, pp. 11614–11623, 2013.

S. M. N. Azmi, P. Jamal, and A. Amid, “Xanthine oxidase inhibitory activity from potential Malaysian medicinal plant as remedies for gout,” International Food Research Journal, vol. 19, no. 1, pp. 159–165, 2012.

K. Reshma and P. B. Arun, “In vitro anti-inflammatory, antioxidant, and nephroprotective studies on leaves of Aegle marmelos and Ocimum sanctum,” Asian Journal of Pharmaceutical and Clinical Research, vol. 7, no. 4, pp. 121–129, 2014.

E. Bursal, E. Köksal, İ. Gülçin, G. Bilsel, and A. C. Gören, “Antioxidant activity and polyphenol content of cherry stem (Cerasus avium L.) determined by LC–MS/MS,” Food Research International, vol. 51, no. 1, pp. 66–74, 2013.

J. A. J. Paul, B. K. Selvi, and N. Karmegam, “Biosynthesis of silver nanoparticles from Premna serratifolia L. leaf and its anticancer activity in CCl4-induced hepato-cancerous Swiss albino mice,” Applied Nanoscience, vol. 5, no. 8, pp. 937–944, 2015.

P. Muthukumaran, S. Salomi, and R. Umamaheshwari, “In vitro antioxidant activity of Premna serratifolia Linn,” Asian Journal of Pharmaceutical Sciences, vol. 3, no. 1, pp. 15–18, 2013.

L. Subedi, S. Timalsena, P. Duwadi, R. Thapa, A. Paudel, and K. Parajuli, “Antioxidant activity and phenol and flavonoid contents of eight medicinal plants from Western Nepal,” Journal of Traditional Chinese Medicine, vol. 34, no. 5, pp. 584–590, 2014.

Z. Sadeghi, J. Valizadeh, O. A. Shermeh, and M. Akaberi, “Antioxidant activity and total phenolic content of Boerhavia elegans (choisy) grown in Baluchestan, Iran,” Avicenna Journal of Phytomedicine, vol. 5, no. 1, pp. 1–9, 2015.

O. M. Ighodaro, “Molecular pathways associated with oxidative stress in diabetes mellitus,” Biomedicine and Pharmacotherapy, vol. 108, pp. 656–662, 2018.

N. Li, F. Frigerio, and P. Maechler, “The sensitivity of pancreatic β-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress,” Biochemical Society Transactions, vol. 36, no. 5, pp. 930–934, 2008.

C. M. O. Volpe, P. H. Villar-Delfino, P. M. F. dos Anjos, and J. A. Nogueira-Machado, “Cellular death, reactive oxygen species (ROS) and diabetic complications,” Cell Death and Disease, vol. 9, no. 2, p. 119, 2018.

C. Supasuteekul, W. Nonthitipong, S. Tadtong, K. Likhitwitayawuid, P. Tengamnuay, and B. Sritularak, “Antioxidant, DNA damage protective, neuroprotective, and α-glucosidase inhibitory activities of a flavonoid glycoside from leaves of Garcinia gracilis,” Revista Brasileira de Farmacognosia, vol. 26, no. 3, pp. 312–320, 2016.

R. K. Salar, S. S. Purewal, and K. S. Sandhu, “Relationships between DNA damage protection activity, total phenolic content, condensed tannin content and antioxidant potential among Indian barley cultivars,” Biocatalysis and Agricultural Biotechnology, vol. 11, pp. 201–206, 2017.

N. R. Perron and J. L. Brumaghim, “A review of the antioxidant mechanisms of polyphenol compounds related to iron binding,” Cell Biochemistry and Biophysics, vol. 53, no. 2, pp. 75–100, 2009.

S. Aydin, A. Basaran, and N. Basaran, “The protective effects of some phenylethanoid glycosides on the mitomycin c induced DNA strand breakage,” Hacettepe üniversitesi eczacılık fakültesi dergisi, vol. 24, no. 1, pp. 1–11, 2004.

A. Kar, B. K. Choudhary, and N. G. Bandyopadhyay, “Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats,” Journal of Ethnopharmacology, vol. 84, no. 1, pp. 105–108, 2003.

Q. Liu, H.-J. Hu, P.-F. Li et al., “Diterpenoids and phenylethanoid glycosides from the roots of Clerodendrum bungei and their inhibitory effects against angiotensin converting enzyme and α-glucosidase,” Phytochemistry, vol. 103, pp. 196–202, 2014.

M. Murai, Y. Tamayama, and S. Nishibe, “Phenylethanoids in the Herb ofPlantago lanceolataand Inhibitory Effect on Arachidonic Acid-Induced Mouse Ear Edema1,” Planta Medica, vol. 61, no. 5, pp. 479-480, 1995.

F. I. Abu Bakar, M. F. Abu Bakar, A. Rahmat, N. Abdullah, S. F. Sabran, and S. Endrini, “Anti-gout potential of Malaysian medicinal plants,” Frontiers in pharmacology, vol. 9, no. 261, 2018.

R. Rajendran and E. Krishnakumar, “Anti-arthritic activity of Premna serratifolia Linn., wood against adjuvant induced arthritis,” Avicenna journal of medical biotechnology, vol. 2, no. 2, pp. 101–106, 2010.

J. Havlik, R. G. de la Huebra, K. Hejtmankova et al., “Xanthine oxidase inhibitory properties of Czech medicinal plants,” Journal of Ethnopharmacology, vol. 132, no. 2, pp. 461–465, 2010.

L.-C. Cheng, V. Murugaiyah, and K.-L. Chan, “Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action,” Journal of Ethnopharmacology, vol. 176, pp. 485–493, 2015.

R. Hellinger and C. W. Gruber, “Peptide-based protease inhibitors from plants,” Drug Discovery Today, vol. 24, no. 9, pp. 1877–1889, 2019.

J. H. Choi, E.-J. Seo, J. Sung et al., “Polyphenolic compounds, antioxidant and anti-inflammatory effects of Abeliophyllum distichum Nakai extract,” Journal of Applied Botany and Food Quality, vol. 90, pp. 266–273, 2017.

Y.-J. Shiao, M.-H. Su, H.-C. Lin, and C.-R. Wu, “Acteoside and isoacteoside protect amyloid β peptide induced cytotoxicity, cognitive deficit and neurochemical disturbances in vitro and in vivo,” International Journal of Molecular Sciences, vol. 18, no. 4, p. 895, 2017.

X.-Y. Zeng, W. Yuan, L. Zhou, S.-X. Wang, Y. Xie, and Y.-J. Fu, “Forsythoside A exerts an anti-endotoxin effect by blocking the LPS/TLR4 signaling pathway and inhibiting Tregs in vitro,” International journal of molecular medicine, vol. 40, no. 1, pp. 243–250, 2017.

A. Sgarbossa, M. Dal Bosco, G. Pressi, S. Cuzzocrea, R. Dal Toso, and M. Menegazzi, “Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors,” Chemico-Biological Interactions, vol. 199, no. 2, pp. 87–95, 2012.

K. H. Kang, S. K. Jang, B.-K. Kim, and M. K. Park, “Antibacterial phenylpropanoid glycosides from Paulownia tomentosa Steud,” Archives of Pharmacal Research, vol. 17, no. 6, pp. 470–475, 1994.

N. Didry, V. Seidel, L. Dubreuil, F. Tillequin, and F. Bailleul, “Isolation and antibacterial activity of phenylpropanoid derivatives from Ballota nigra,” Journal of ethnopharmacology, vol. 67, no. 2, pp. 197–202, 1999.

A. Savtschenko, S. Dhein, and H. Rauwald, “The antiarrhythmic effects of lavandulifolioside and ferulic acid from Leonurus cardiaca extracts on cardiac electrophysiology,” Zeitschrift für Phytotherapie, vol. 34, no. S 01, 2013.

H. Fleer and E. J. Verspohl, “Antispasmodic activity of an extract from Plantago lanceolata L. and some isolated compounds,” Phytomedicine, vol. 14, no. 6, pp. 409–415, 2007.

L. Naso, V. R. Martínez, L. Lezama et al., “Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin,” Bioorganic and Medicinal Chemistry, vol. 24, no. 18, pp. 4108–4119, 2016.

W. Wojnar, I. Kaczmarczyk-Sedlak, and M. Zych, “Diosmin ameliorates the effects of oxidative stress in lenses of streptozotocin-induced type 1 diabetic rats,” Pharmacological Reports, vol. 69, no. 5, pp. 995–1000, 2017.

X. Zhang, J.-K. Xu, J. Wang et al., “Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile,” Journal of Natural Products, vol. 70, no. 1, pp. 24–28, 2007.